| 铁螯合剂去铁斯若的药理与临床评价 |
| |
| 引用本文： | 韩莹,史爱欣,傅得兴. 铁螯合剂去铁斯若的药理与临床评价[J]. 中国新药杂志, 2007, 16(8): 653-655 |
| |
| 作者姓名： | 韩莹 史爱欣 傅得兴 |
| |
| 作者单位： | 卫生部北京医院药学部,北京,100730 |
| |
| 摘 要： | 去铁斯若是首个1日1次的口服铁螯合剂，用于治疗成人和2岁及以上儿童由于输血引起的慢性铁超负荷。现对其药理作用、药动学、临床评价以及安全耐受性做一综述。
|
| 关 键 词： | 去铁斯若 铁螯合剂 药理作用 临床评价 安全性 |
| 文章编号： | 1003-3734（2007）08-0653-03 |
Pharmacology and clinical evaluation of deferasirox |
| |
| HAN Ying,SHI Ai-xin,FU De-xing. Pharmacology and clinical evaluation of deferasirox[J]. Chinese Journal of New Drugs, 2007, 16(8): 653-655 |
| |
| Authors: | HAN Ying SHI Ai-xin FU De-xing |
| |
| Affiliation: | Department of Pharmacy, Beijing Hospital, Beijing 100730, China |
| |
| Abstract: | Deferasirox(Exjade) is a novel oral iron chelator that was administered once daily.Deferasirox was approved for treatment of chronic iron overload due to chronic blood transfusion therapy for adults and children at age of two years and above.This paper summarizes the pharmacological effect and clinical evaluation of deferasirox. |
| |
| Keywords: | deferasirox iron chelator pharmacological effect clinical evaluation safety |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
| 点击此处可从《中国新药杂志》浏览原始摘要信息 |
